Novel, Selective CDK9 Inhibitors for the Treatment of HIV Infection
Keywords: 4-aminophenyl-6-phenyl-pyrimidine; ATP-binding; Alzheimer's disease; CDK9; Flavopiridol; HIV; Herpes Simplex Virus; RNA polymerase; Sulfone groups; alsterpaullone; aminophenyl ring; boronic acids; cancer cells; carbazoles; cardiology; cell-division cycle; chloro-pyrimidines; chloropyrimidine; co-crystallization; colorectal tumours; cyclin-dependent kinases; docking; ephosphorylation; flavopiridol; hydrolysis; hypertension; inflammatory diseases; intermediate; kinase inhibitor; ligands; mitosis; nucleotide analogue; oncology; oxygen concentration; pathologic cellular; pharmacophore points; phosphorylates retinoblastoma1 protein; phosphorylation; selectivity; staurosporin; synthesis; trifocal complex; viral transcription; virology; xylocydine
Document Type: Research Article
Publication date: 2011-01-01
- Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.